Memories are not formed instantaneously. Instead, following initial encoding, memories appear to undergo a prolonged period of reorganization (McClelland et al. 1995; Squire and Alvarez 1995; Dudai 2004; Wiltgen et al. 2004; Frankland and Bontempi 2005) . The result of this reorganization is that circuits underlying encoding or initial storage may differ from those required for permanent storage. This type of reorganization has most often been studied in cortico-hippocampal circuits (Squire et al. 2004; Frankland and Bontempi 2005) . However, time-dependent reorganization is observed across many different memory systems (Shadmehr and Holcomb 1997; Tronel and Sara 2002; Bahar et al. 2004 ) and in many different species, including invertebrates (McBride et al. 1999; Menzel 2001; Keller et al. 2005) . While these studies indicate that reorganization might be a somewhat ubiquitous process during memory maturation, its exact purpose is still not clear. Because behavioral expression of memory doesn't necessarily change over time, one possibility is that reorganization leads to greater memory stability Alberini 2005; Stickgold and Walker 2005) .
One way to probe memory stability is to apply consolidation blockers (e.g., protein synthesis inhibitors) during or immediately following memory retrieval. Such manipulations interfere with the restabilization (or reconsolidation) of memories, leading to amnesia (Nader 2003) . While reconsolidation has now been demonstrated across species and memory paradigms (Nader 2003; Dudai and Eisenberg 2004) , post-reactivation protein synthesis blockade does not always lead to amnesia (Vianna et al. 2001; Kraus et al. 2002; Biedenkapp and Rudy 2004; Cammarota et al. 2004; Pedreira et al. 2004) . One important variable appears to be the age of the memory. Recent studies in rodents (Milekic and Alberini 2002; Suzuki et al. 2004) , as well as medaka fish , have shown that as memories mature they become increasingly immune to disruption by proteinsynthesis blockers. This suggests that there might be a trade-off between plasticity and stability as memories age.
This age-stability relationship has so far only been investigated using systemically applied consolidation blockers (Milekic and Alberini 2002; Eisenberg and Dudai 2004; Suzuki et al. 2004 ). However, we have recently mapped brain regions involved in the recall of recent and remote contextual fear memories in mice ). These studies showed that the dHPC was strongly activated only following recall of the recent (day-old) fear memory. In contrast, a number of different cortical regions (including the ACC) were strongly activated only following recall of the remote (month-old) fear memory. Here we target these regions to probe the stability of recent and remote contextual fear memories. Using identical apparatus and procedures as in our mapping studies , we examined the effects of post-reactivation blockade of protein synthesis on subsequent expression of recent and remote contextual fear memory.
mice received intra-ACC infusions of PBS or ANI. Thirty minutes following this pretreatment, mice received PTZ (50 mg/kg, ip). This dose of PTZ produced clonic convulsions (i.e., sudden twitching of head or jerky movement of body) in the majority of mice, and strong Fos expression throughout the brain (including the ACC). Importantly, Fos expression in the ACC was reduced by over 50% in mice pretreated with ANI, consistent with the idea that ANI attenuates protein synthesis (t (13) = 5.94, P < 0.05) (Fig. 1 ). This reduction in Fos expression was evident in a roughly circular region 1.0-1.5 mm in diameter, below the tip of the injector. This indicates that infusions were largely restricted to the ACC, with limited diffusion to neighboring structures.
In the second study, mice were pretreated with systemic injections of PBS or ANI. Again, PTZ treatment induced strong Fos expression and this expression was reduced by ANI pretreatment in the ACC (PBS: 13.94 ‫ע‬ 0.89; ANI: 6.21 ‫ע‬ 0.89 [t (8) = 6.21, P < 0.05]), as well as other cortical regions, including the retrosplenial (PBS: 9.14 ‫ע‬ 1.08; ANI: 0.50 ‫ע‬ 0.14 [t (12) = 7.95, P < 0.05]) and perirhinal (PBS: 5.04 ‫ע‬ 1.12; ANI: 1. 16 ‫ע‬ 0.27 [t (12) = 3.38, P < 0.05]) cortex (Fig. 2) . Together these studies establish that the ANI manipulations used in the behavioral studies disrupt protein synthesis, measured here as a reduction in Fos expression induced by the chemical convulsant, PTZ.
Post-reactivation blockade of protein synthesis in the dHPC disrupts subsequent expression of recent, but not remote, contextual fear memory
In this first series of behavioral experiments, mice were trained with three footshocks. Then, either 1-d (recent) or 36-d (remote) later mice were placed back into the context for 2.5 min (reexposure). Immediately following this context re-exposure, mice received infusions of ANI into the dHPC. One day following this, they were tested.
We found that the destabilizing effects of blocking protein synthesis in the dHPC following memory recall depended on the age of the memory (Fig. 3) . All groups of mice exhibited similar levels of freezing when re-exposed to the conditioning context (Recent: F (1,14) = 0.06, P > 0.05; Remote: F (1,18) = 0.16, P > 0.05). However, intra-dHPC infusions of ANI following the retrieval of a 1-d-old (recent) contextual fear memory blocked expression of that memory tested one day later (F (1,14) = 11.34, P < 0.05) (Fig.  3A) . In contrast, similar infusions following the retrieval of 36-d-old (remote) contextual fear memory had no effect on subsequent memory expression (F (1,18) = 0.44, P > 0.05) (Fig. 3B ).
These data indicate that infusions of ANI into the dHPC disrupt reconsolidation of recent, but not remote, contextual fear memories (delay ‫ן‬ drug interaction: F (1,32) = 4.99, P < 0.05) (Fig. 3C ). This effect on recent memory was contingent on memory reactivation. When the reactivation was omitted, similar ANI infusions had no effect on subsequent expression of that memory tested 1 d later (F (1,15) = 0.69, P > 0.05) (Fig. 3D) .
To explore the generality of this effect on recent contextual fear memories, we also trained another set of mice with a single footshock and re-exposed them to the conditioning chamber 1-d later.
As before, we found that ANI infusions disrupted reconsolidation of a recent contextual fear memory (F (1,11) = 5.76, P < 0.05) (Fig. 3E) , demonstrating that ANI blocks reconsolidation of recent contextual fear memories regardless of whether mice are weakly or strongly fear conditioned. Histological analyses revealed that the tips of the guide cannulae were correctly located just dorsal to the dHPC in these experiments.
Post-reactivation blockade of protein synthesis in the ACC has no effect on subsequent expression of recent or remote contextual fear memory
We previously found that the ACC is activated following recall of remote contextual fear memory. Further experiments showing that (1) this activity is absent in ␣-CaMKII ‫מ/+‬ mice that are unable to form remote memories, and (2) localized inactivation of this region specifically blocks remote memory, suggested that the ACC plays a crucial role in remote memory recall ). Therefore, we next examined the impact of blocking protein synthesis in the ACC on the stability of both recent and remote contextual fear memories (Fig. 4) . Again, mice were trained with three footshocks, and 1 or 36 d later placed back in the conditioning context for 2.5 min. During this re-exposure phase, all groups of mice exhibited simil a r l e v e l s o f f r e e z i n g ( R e c e n t : F ( 1 , 1 5 ) = 0 . 1 1 , P > 0 . 0 5 ; R e m o t e : F (1,18) = 0.23, P > 0.05). In contrast to the hippocampus, intra-ACC infusions of ANI following the retrieval of either recent (F (1,15) = 0.51, P > 0.05) or remote (F (1,18) = 0.14, P > 0.05) contextual fear memory had no effect on subsequent memory expression (Fig. 4A,B ). This result is confirmed by the absence of a significant delay ‫ן‬ drug interaction (F (1,33) = 0.36, P > 0.05) (Fig. 4C ). Therefore, whereas inactivation of the ACC blocks retrieval of 36-d-old (remote) contextual fear memories , blocking protein synthesis following retrieval does not affect subsequent stability of that memory. Histological analyses revealed that the tips of the guide cannulae were correctly located just dorsal to the ACC in these and all following experiments.
Intra-ACC blockade of protein synthesis fails to disrupt reconsolidation of remote contextual fear memory following extended context re-exposure
The duration of re-exposure is an important variable in reconsolidation experiments. Previous studies have established that longer duration re-exposures tend to have greater destabilizing effects on memory than shorter ones (Pedreira and Maldonado 2003; Suzuki et al. 2004 ). We therefore tested whether intra-ACC infusions of ANI block reconsolidation when longer re-exposure durations were used (Fig. 5A ). Mice were trained as above and then 36 d later reexposed to the conditioning context for either 10 or 15 min. These re-exposures should be maximally destabilizing since longer duration re-exposures produce significant extinction (Suzuki et al. 2004) . Indeed, while all groups of mice exhibited similar levels of freezing during the re-exposure phase (10 min: F (1,17) = 3.60, P > 0.05; 15 min: F (1,17) = 0.05, P > 0.05), overall Post-reactivation blockade of protein synthesis in dHPC. Intra-dHPC infusions of ANI following context re-exposure disrupted subsequent expression of recent (A), but not remote (B), contextual fear memory. The percent time spent freezing is shown during the training (TR), re-exposure (RE), and test phases (TE) of the experiment. A summary of the test freezing scores for these mice is shown in C. The destabilizing effects of intra-dHPC ANI on recent contextual fear memory are contingent on memory reactivation. When context re-exposure was omitted, ANI infusions into the dHPC had no effect on subsequent memory expression (D). Intra-dHPC infusions of ANI also block reconsolidation of a weaker contextual fear memory. In this experiment, mice were trained with one, rather than three shocks (E). Significant differences are marked by an asterisk (*P < 0.05, see text for details).
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www.learnmem.org on May 9, 2007 www.learnmem.org Downloaded from freezing levels were lower in mice re-exposed for 15 min, suggesting that this longer duration re-exposure may start to produce some extinction. In either case, intra-ACC infusions of ANI following either the 10-min (F (1,17) = 0.16, P > 0.05) or 15-min (F (1,17) = 1.98, P > 0.05) re-exposure had no effect on subsequent contextual fear memory expression tested 1-d later. These results indicate that post-reactivation infusions of ANI into the ACC fail to disrupt subsequent expression of remote contextual fear memories, even when longer duration re-exposures are used.
Systemic ANI injections disrupt reconsolidation of remote contextual fear memories following extended duration context re-exposures One reason why reactivated remote contextual memories may be insensitive to the amnesic effects of ANI is because they are supported by distributed cortical networks (McClelland et al. 1995; Frankland and Bontempi 2005) . It is possible that a more global, cortex-wide disruption of protein synthesis would block the reconsolidation of remote contextual fear memories. To test this, we examined the effects of systemically administered ANI on remote contextual fear memory. In the first series of experiments (Fig. 5B ), mice were trained as above and 36 d later re-exposed to the conditioning context for either 10 or 15 min. Prior to this re-exposure, mice received injections of ANI (150 mg/kg, i.p.) or PBS. Both ANI-and PBS-treated mice exhibited similar levels of freezing when re-exposed to the conditioning context (10 min: F (1,18) = 0.18, P > 0.05; 15 min: F (1,18) = 0.04, P > 0.05). However, only ANI injections prior to the 15-min re-exposure disrupted subsequent memory tested 1 d later (F (1,18) = 6.16, P < 0.05). Similar infusions prior to the 10 min re-exposure had no effect on s u b s e q u e n t m e m o r y e x p r e s s i o n (F (1,18) = 0.30, P > 0.05).
In the previous central injection experiments, ANI was infused after, rather than before context re-exposure. Therefore, we ran an additional experiment where mice received systemic injections of ANI or PBS immediately after a 15-min re-exposure. Mice in the ANI and PBS groups exhibited similar levels of freezing during the re-exposure phase (F (1,18) = 1.42, P > 0.05). However, consistent with our earlier results, systemic ANI treatment disrupted subsequent memory tested 1 d later (F (1,18) = 29.73, P < 0.05) (Fig. 5C ). Finally, we tested whether this effect was contingent on memory reactivation. When this reactivation was omitted, similar ANI injections had no effect on subsequent expression of that memory tested 1 d later (F (1,15) = 0.05, P > 0.05) (Fig. 5C ).
These data indicate that systemic ANI injections disrupt reconsolidation of remote contextual fear memories, but only when longer duration re-exposures are used. The effects of systemically administered ANI contrast with those of intra-ACC infused ANI. Under identical conditions, local blockade of protein Figure 5 . Effects of context re-exposure duration on reconsolidation of remote contextual fear memory. For each experiment, the percent time spent freezing is shown during the training (TR), re-exposure (RE), and test phases (TE) of the experiment. (A) Intra-ACC infusions of ANI had no effect on subsequent expression of remote contextual fear memory using either 10-or 15-min context re-exposures. These test data are summarized in the graph on the far right. (B) Systemic injections of ANI blocked reconsolidation of remote contextual fear memory only when the longer (15-min) context re-exposure was used. These test data are summarized in the graph on the far right. (C) Systemic injection of ANI immediately following (rather than preceding) a 15-min re-exposure also blocks reconsolidation (left). The destabilizing effects of ANI on remote contextual fear memory are contingent on memory reactivation. When context re-exposure was omitted, systemic ANI injections had no effect on subsequent memory expression (right). Significant differences are marked by an asterisk (*P < 0.05, see text for details). synthesis in the ACC had no effect on subsequent memory expression, suggesting that a more global disruption of protein synthesis is necessary to destabilize remote memory. This is different from the situation for recent contextual fear memories. Both local (dHPC) (present study; Suzuki et al. 2004) or systemic (Suzuki et al. 2004 ) blockade of protein synthesis disrupts reconsolidation of recent contextual fear memories.
Discussion
We used a contextual fear-conditioning paradigm in mice to examine how time-dependent reorganization might affect memory stability. Two features of contextual fear conditioning make it especially suited for this analysis. First, contextual fear conditioning has been used extensively to study behavioral and molecular determinants of reconsolidation in mice (Kida et al. 2002; Biedenkapp and Rudy 2004; Fischer et al. 2004; Lattal and Abel 2004; Suzuki et al. 2004; von Hertzen and Giese 2005) , as well as other species (Debiec et al. 2002; Pedreira and Maldonado 2003; Biedenkapp and Rudy 2004; Lee et al. 2004; Pedreira et al. 2004; Merlo et al. 2005) . Second, imaging and lesion experiments indicate that the circuits supporting contextual fear undergo significant reorganization in the month following learning (Anagnostaras et al. 1999; Shimizu et al. 2000; Frankland et al. 2001 Frankland et al. , 2004 . The current experiments indicate that blocking protein synthesis in the dHPC disrupts recent, but not remote contextual fear memories. Similar infusions into the ACC had no effect on either recent or remote contextual fear memories, whereas systemically applied ANI blocked subsequent remote memory expression when long re-exposure durations were used. Together, these data suggest that as memories mature they become increasingly stable. Furthermore, the dissociation between the effects of systemically and centrally administered ANI on remote memory suggests that stability is due, in part, to the distributed nature of remote contextual fear memories.
The effects of intra-dHPC infusions of ANI on the stability of recent and remote contextual fear memory parallels the timedependent role the hippocampus plays in the storage of these types of memories. Using identical apparatus, behavioral procedures, and retention delays, we previously showed that the hippocampus was activated following recall of recent, but not remote contextual fear memory ). Here we found that blocking protein synthesis in the dHPC-disrupted reconsolidation of recent contextual fear memories, regardless of whether mice had been trained using a weak (one-shock) or strong (three-shock) protocol. However, we found that similar infusions had no effect on remote contextual fear memories, consistent with the lack of involvement of the dHPC in processing contextual fear memories at later time points (Hall et al. 2001; Frankland et al. 2004; von Hertzen and Giese 2005) . This was still the case even when a longer re-exposure (10-min) was used (data not shown). This lack of effect on remote contextual fear memory contrasts with a previous study in rats (Debiec et al. 2002) . In this study, intrahippocampal infusions of ANI blocked reconsolidation of both recent (1-d-old) and remote (i.e., 45-dold) contextual fear memories. This discrepancy may reflect species differences between rats and mice. Alternatively, it is possible that infusion of a larger volume or dose would be more effective in destabilizing remote memory in our study. However, our data clearly demonstrate a time-dependent stability gradient, with recent memories more sensitive to intra-dHPC infusions of ANI compared with remote memories.
We previously found that the ACC was activated following recall of remote (but not recent) contextual fear memories, and that inactivation of the ACC specifically disrupts recall of these memories ). Here we found that postretrieval blockade of protein synthesis in the ACC does not destabilize remote contextual fear memories. This lack of effect on remote memories suggests two possibilities. First, the ACC may only be necessary for retrieval (and not storage) of remote contextual fear memories. Such a situation would suggest a division of labor in the cortex with the ACC coordinating retrieval of memories that are stored in more posterior cortical regions (Frankland and Bontempi 2005) . If this were the case, then postreactivation disruption of protein synthesis in more posterior cortical regions might disrupt the reconsolidation of remote contextual fear memories.
A second possibility is that the distributed nature of remote memory protects against the destabilizing effects of locally applied protein synthesis inhibitors. Using cellular imaging approaches, we have previously shown that recall of remote contextual fear memory is associated with activation of multiple cortical regions , suggesting that remote contextual fear memories are supported by a broadly distributed network. In the present series of experiments, we found that only systemically applied ANI disrupted subsequent expression of remote contextual fear memory, albeit only when a longer duration context re-exposure was used. Therefore, whereas local blockade of protein synthesis in the dHPC was sufficient to destabilize a recent contextual fear memory, a more global disruption of protein synthesis appears to be necessary to destabilize remote contextual fear memory.
Together, these experiments have started to explore the relationship between memory age and memory stability. Consistent with previous reports (Milekic and Alberini 2002; Pedreira and Maldonado 2003; Suzuki et al. 2004) , our data indicate that as memories mature they become increasingly immune to the destabilizing effects of protein-synthesis blockers. Gradual reorganization of contextual fear memories in distributed cortical (or cortico-hippocampal) networks (McClelland et al. 1995; Nadel and Moscovitch 1997; Squire et al. 2004; Wiltgen et al. 2004; Frankland and Bontempi 2005) may underlie this increased stability.
Materials and Methods
Animals
Male C57Bl/6 mice were used in these experiments. For the local infusion experiments, these mice were purchased from Taconic Farms. For the systemic injection experiments, they were purchased from Charles River. Mice were maintained on a 12-h light/12-h dark cycle, and had free access to food and water. Mice were at least 8 wk of age at the start of experiments, and all behavioral procedures were conducted during the light phase of the cycle. Experiments were conducted blind to the treatment condition of the mouse.
Surgery
Under chloral hydrate anesthesia and using standard stereotaxic procedures, stainless-steel guide cannulae (22-gauge) were implanted into the dHPC ‫0.2מ(‬ mm, ‫0.2ע‬ mm, ‫0.2מ‬ mm) or ACC (+0.8 mm, 0 mm, ‫0.1מ‬ mm). Mice were allowed to recover for at least 1 wk following surgery. Following this, they were handled for three consecutive days prior to the commencement of contextual fear conditioning.
Drugs and infusion procedures
The protein synthesis inhibitor, Anisomycin (ANI; Sigma), was used in these experiments. For the local infusion studies, ANI (100 µg/µL) was dissolved in phosphate-buffered saline (PBS) and the pH-adusted to 7.0-7.4. ANI was infused immediately following the re-exposure phase of the experiment. Mice were briefly anesthetized with halothane to facilitate insertion of the injec-
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www.learnmem.org on May 9, 2007 www.learnmem.org Downloaded from tion cannula. Infusions into the dHPC (0.75 µL) or ACC (0.50 µL) were made at a rate of 0.2 µL/min. The injection cannula (26-gauge) was left in place for 2 min following the infusion. This dose of locally infused ANI inhibits >90% of protein synthesis for at least 4 h (Rosenblum et al. 1993) . For the systemic injection experiments, ANI (150 mg/kg, i.p.) was injected 30 min prior to the re-exposure phase of the experiment. At this dose, ANI inhibits >90% of protein synthesis in the brain in the first 2 h following injection (Flood et al. 1973 ).
Effect of ANI manipulations on c-fos expression
To indirectly examine the impact of ANI on protein synthesis inhibition, separate groups of mice received infusions of either PBS (n = 8) or ANI (n = 7) into the ACC, as described above. Thirty minutes following this, mice were administered the chemical convulsant pentylenetetrazol (PTZ; 50 mg/kg, ip), and then 30 min later perfused transcardially. Brains were subsequently prepared for immunocytochemistry using anti-Fos primary rabbit polyclonal antibody (1:20000), as previously described . Staining was revealed using the avidin-biotin peroxidase method (ABC kit). Quantitative analysis was performed using a NIH image-processing system and brain regions were anatomically defined according to the Paxinos and Franklin atlas (Paxinos and Franklin 2000) . Immunoreactive neurons were counted by an experimenter unaware of the treatment condition.
In a second experiment, mice received systemic injections of either PBS or ANI, as described above. Thirty minutes later they were administered PTZ (50 mg/kg, ip), and then 30 min later perfused transcardially. Brains were subsequently prepared for Fos immunocytochemistry as above. The advantage of using PTZ in these experiments is that it induces high levels of Fos expression. This makes it easier to detect any reductions in Fos expression produced by pretreatment with ANI.
Contextual fear-conditioning procedures
The apparatus and general procedures for contextual fear conditioning have previously been described (Anagnostaras et al. 2000; Frankland et al. 2004; Suzuki et al. 2004) . Mice were trained and tested in a conditioning chamber (32 cm ‫ן‬ 25 cm ‫ן‬ 25 cm), containing a stainless-steel shock-grid floor. For the systemic injection experiments, a similar, but smaller (17.5 cm ‫ן‬ 17.5 cm ‫ן‬ 15 cm), conditioning chamber was used.
Each experiment consisted of three phases: Training, reexposure, and testing. During each of these phases, freezing behavior (defined as a complete absence of movement, except for respiration) (Fanselow 1980) was measured using automated procedures (Anagnostaras et al. 2000) .
In the first series of experiments, during training, mice were placed in the conditioning chamber for 5 min. After 2 min they were presented with three unsignaled footshocks (2-sec duration, 0.75 mA, 1 min apart). During the re-exposure phase, mice were placed back into the conditioning context for 2.5 min either 1 or 36 d later. Immediately following this re-exposure, mice received infusions of PBS or ANI into the dHPC or ACC, respectively. One day later, contextual fear memory was assessed in a 2-min test. Mouse numbers were as follows: dHPC recent (PBS n = 9; ANI n = 7); dHPC remote (PBS n = 9; ANI n = 11); ACC recent (PBS n = 7; ANI n = 10); ACC remote (PBS n = 13; ANI n = 7).
In the second series of experiments, we first examined the effects of omitting the re-exposure. Accordingly, mice were trained as above with three footshocks. One day later they received infusions of PBS (n = 9) or ANI (n = 8) into the dHPC, but were not re-exposed to the conditioning chamber. The following day, contextual fear memory was assessed in a 2-min test. In a second experiment, we tested whether ANI disrupts reconsolidation of a weaker contextual fear memory. In this experiment, mice were trained with a single footshock (a 0.75 mA shock, delivered after 2 min of a 3-min training session) and re-exposed to the conditioning chamber for 2.5 min the following day. Immediately following this re-exposure, mice received infusions of either PBS (n = 5) or ANI (n = 8) into the dHPC. One day later, contextual fear memory was assessed in a 2-min test.
In the third series of experiments, we examined the effects of using longer duration context re-exposures on memory stability. Again, mice were trained with three footshocks. Thirty-six days later, they were re-exposed to the conditioning context for either 10 or 15 min. For the local infusion experiments, mice received infusions of PBS (10 min, n = 9; 15 min, n = 13) or ANI (10 min, n = 10; 15 min, n = 6) into the ACC immediately following this re-exposure. For the systemic injection experiments, mice received PBS (10 min, n = 10; 15 min, n = 10) or ANI (10 min, n = 10; 15 min, n = 10) injections 30 min before the reexposure. One day later, contextual memory was assessed in a 2-min test.
In addition, we also tested whether systemically administered ANI would have the same effects if injected immediately following the re-exposure. In this experiment, mice were trained as before with three footshocks. Then, 36 d later they were reexposed to the conditioning context for 15 min. Immediately following this re-exposure mice received PBS (n = 10) or ANI (n = 10) injections and contextual fear memory was then assessed in a 2-min test the following day. In a separate group of mice, we examined the effects of omitting the re-exposure. Accordingly, mice were trained as above with three footshocks. Thirty-six days later they received systemic injections of PBS (n = 10) or ANI (n = 10), but were not re-exposed to the conditioning chamber. The following day, contextual fear memory was assessed in a 2-min test.
Histology
At the completion of the experiments, mice were overdosed with chloral hydrate and perfused transcardially with saline, followed by 4% formaldehyde solution to fix the brain tissue. Brains were removed, post-fixed in 4% formaldehyde solution, and cut into 50-µm coronal sections on a cryostat. Sections were mounted on slides, stained with neutral red, and cannula placements were examined under a light microscope.
Statistical analyses
Separate ANOVAs were performed to determine the effects of ANI on freezing in the re-exposure and retention tests in each of the conditions (e.g., dHPC/recent, dHPC/remote, etc). In addition, two-way ANOVAs (drug [ANI, PBS] ‫ן‬ delay [recent, remote]) were used to evaluate whether these treatments differentially affected recent vs. remote memory. t-tests were used to analyze the effects of ANI treatment on Fos expression.
